AU8016398A - Peptides with antiviral activity - Google Patents

Peptides with antiviral activity

Info

Publication number
AU8016398A
AU8016398A AU80163/98A AU8016398A AU8016398A AU 8016398 A AU8016398 A AU 8016398A AU 80163/98 A AU80163/98 A AU 80163/98A AU 8016398 A AU8016398 A AU 8016398A AU 8016398 A AU8016398 A AU 8016398A
Authority
AU
Australia
Prior art keywords
peptides
antiviral activity
antiviral
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU80163/98A
Inventor
Paolo Lusso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fondazione Centro San Raffaele del Monte Tabor
Original Assignee
SAN RAFFAELE CENTRO FOND
Fondazione Centro San Raffaele
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SAN RAFFAELE CENTRO FOND, Fondazione Centro San Raffaele filed Critical SAN RAFFAELE CENTRO FOND
Publication of AU8016398A publication Critical patent/AU8016398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU80163/98A 1997-05-12 1998-05-11 Peptides with antiviral activity Abandoned AU8016398A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT97MI001105A IT1291353B1 (en) 1997-05-12 1997-05-12 PEPTIDES WITH ANTIVIRAL ACTIVITY
ITMI97A1105 1997-05-12
PCT/EP1998/002750 WO1998051705A1 (en) 1997-05-12 1998-05-11 Peptides with antiviral activity

Publications (1)

Publication Number Publication Date
AU8016398A true AU8016398A (en) 1998-12-08

Family

ID=11377117

Family Applications (1)

Application Number Title Priority Date Filing Date
AU80163/98A Abandoned AU8016398A (en) 1997-05-12 1998-05-11 Peptides with antiviral activity

Country Status (3)

Country Link
AU (1) AU8016398A (en)
IT (1) IT1291353B1 (en)
WO (1) WO1998051705A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743594B1 (en) 1995-06-06 2004-06-01 Human Genome Sciences, Inc. Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5)
US6025154A (en) 1995-06-06 2000-02-15 Human Genome Sciences, Inc. Polynucleotides encoding human G-protein chemokine receptor HDGNR10
WO2000009152A1 (en) * 1998-08-14 2000-02-24 The University Of British Columbia Therapeutic chemokine receptor antagonists
DE69914463T2 (en) 1998-03-13 2004-11-11 The University Of British Columbia, Vancouver THERAPEUTIC CHEMOKINE RECEPTOR ANTAGONISTS
CA2305787A1 (en) 2000-05-09 2001-11-09 The University Of British Columbia Cxcr4 antagonist treatment of hematopoietic cells
CA2245224A1 (en) 1998-08-14 2000-02-14 Jiang-Hong Giong Chemokine receptor antagonists and chemotherapeutics
IT1303736B1 (en) 1998-11-11 2001-02-23 San Raffaele Centro Fond PEPTIDES DERIVED FROM RANTES WITH ANTI-HIV ACTIVITY.
AU2001249194A1 (en) * 2000-03-23 2001-10-03 Phylomed Corporation Immunokine composition and method
US20050059584A1 (en) 2002-08-16 2005-03-17 Ahmed Merzouk Novel chemokine mimetics synthesis and their use
US7368425B2 (en) 2006-03-24 2008-05-06 Chemokine Therapeutics Corp. Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis
US7378098B2 (en) 2000-04-12 2008-05-27 The University Of British Columbia CXC chemokine receptor 4 agonist peptides
FR2838444B1 (en) * 2002-04-10 2016-01-01 Neovacs NEW PEPTIDES AND THEIR THERAPEUTIC APPLICATION
JP2007537148A (en) * 2003-12-30 2007-12-20 ワイス Antiviral composition that inhibits paramyxovirus infection
EP1723178A4 (en) 2004-03-12 2007-12-12 Human Genome Sciences Inc Human g-protein chemokine receptor (ccr5) hdgnr10
DK2185719T3 (en) * 2007-08-02 2014-02-17 Novimmune Sa ANTI-RANTES ANTIBODIES AND PROCEDURES FOR USE THEREOF

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3623985B2 (en) * 1993-05-31 2005-02-23 財団法人化学及血清療法研究所 Anti-LD78 polypeptide monoclonal antibody
US6159711A (en) * 1994-12-08 2000-12-12 Glaxo Group Limited DNA encoding rantes peptide fragments and methods of treatment with the fragments
FR2748938B1 (en) * 1996-05-22 1998-07-31 Pasteur Institut USE OF ANTAGONIST MOLECULES OF CHEMOKINES FOR THEIR ANTIVIRAL ACTIVITY IN PARTICULAR AGAINST HIV-TYPE RETROVIRUSES
WO1998006751A1 (en) * 1996-08-16 1998-02-19 Research Corporation Technologies, Inc. Mcp-3, rantes and mip-1alpha receptor antagonists
EP0972043A1 (en) * 1996-09-25 2000-01-19 British Biotech Pharmaceuticals Limited Human rantes mutants incapable of aggregate formation

Also Published As

Publication number Publication date
ITMI971105A0 (en) 1997-05-12
ITMI971105A1 (en) 1998-11-12
WO1998051705A1 (en) 1998-11-19
IT1291353B1 (en) 1999-01-07

Similar Documents

Publication Publication Date Title
AU8597498A (en) Distributed computing architecture
AU1407699A (en) Distributed architecture utility
AU5551098A (en) Antiviral peptide derivatives
AU6208098A (en) Protein with phospholipase activity
AU1709299A (en) Mixer-injectors
AU8968198A (en) Wrist support
AU6399798A (en) New catalysts
AUPP029497A0 (en) Wrist support
AU1582599A (en) Antenna with plasma-grating
AU8016398A (en) Peptides with antiviral activity
IL128517A (en) Dihydropyrones with improved antiviral activity
AU1172599A (en) Compounds with antitumor activity
AU1527499A (en) Pen
AUPO912997A0 (en) Antiviral agents
EP0903415A3 (en) Structure expansée
AU4030697A (en) Proteins having telomerase activity
AU2377097A (en) Antiviral ricin-like proteins
AU2660400A (en) Rantes-derived peptides with anti-hiv activity
AU7244998A (en) Chemokine beta-6
AU1999999A (en) Contryphan peptides
AU9261198A (en) Antiviral agent
AU6673898A (en) Factor x variant
AU5678798A (en) Antiviral agents
AU1541399A (en) Human nucleotide pyrophosphohydrolase-2
AU7273098A (en) Hyperstructure-forming carriers

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase